DnB Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.7M Buy
116,514
+4,207
+4% +$1.16M 0.07% 181
2026
Q1
$33.2M Buy
112,307
+2,051
+2% +$609K 0.12% 135
2025
Q4
$30.1M Buy
110,256
+34,298
+45% +$9.32M 0.11% 136
2025
Q3
$20.5M Sell
75,958
-18,380
-19% -$5M 0.08% 182
2025
Q2
$26M Sell
94,338
-33,587
-26% -$9.13M 0.11% 141
2025
Q1
$33.9M Sell
127,925
-11,056
-8% -$2.73M 0.16% 110
2024
Q4
$32.3M Buy
138,981
+1,119
+0.8% +$257K 0.14% 120
2024
Q3
$30.4M Buy
137,862
+76,788
+126% +$15.9M 0.14% 123
2024
Q2
$12M Buy
61,074
+4,286
+8% +$886K 0.06% 202
2024
Q1
$12.2M Sell
56,788
-41,529
-42% -$8.72M 0.06% 208
2023
Q4
$20.7M Buy
98,317
+25,257
+35% +$5.39M 0.11% 159
2023
Q3
$14.6M Sell
73,060
-14,778
-17% -$2.94M 0.09% 185
2023
Q2
$16.3M Buy
87,838
+19,065
+28% +$3.52M 0.09% 166
2023
Q1
$13.2M Buy
68,773
+42
+0.1% +$7.59K 0.08% 182
2022
Q4
$11.6M Buy
68,731
+1,001
+1% +$174K 0.08% 198
2022
Q3
$12M Buy
67,730
+1,333
+2% +$263K 0.09% 184
2022
Q2
$13.6M Buy
66,397
+1,298
+2% +$275K 0.1% 180
2022
Q1
$15.5M Buy
65,099
+3,454
+6% +$811K 0.09% 175
2021
Q4
$14.1M Buy
61,645
+6,297
+11% +$1.39M 0.08% 193
2021
Q3
$10.7M Buy
55,348
+1,622
+3% +$329K 0.07% 218
2021
Q2
$11.4M Buy
53,726
+2,357
+5% +$498K 0.08% 204
2021
Q1
$10.5M Buy
51,369
+802
+2% +$158K 0.08% 202
2020
Q4
$9.21M Buy
50,567
+2,472
+5% +$420K 0.08% 184
2020
Q3
$8.05M Buy
48,095
+6,845
+17% +$1.15M 0.09% 169
2020
Q2
$6.7M Sell
41,250
-3,082
-7% -$552K 0.08% 179
2020
Q1
$7.67M Buy
44,332
+1,081
+2% +$215K 0.11% 140
2019
Q4
$8.68M Buy
43,251
+4,775
+12% +$980K 0.09% 174
2019
Q3
$8.13M Buy
38,476
+236
+0.6% +$49.3K 0.09% 178
2019
Q2
$7.42M Sell
38,240
-2,817
-7% -$519K 0.09% 185
2019
Q1
$6.76M Sell
41,057
-3,637
-8% -$643K 0.08% 177
2018
Q4
$8.41M Buy
44,694
+2,261
+5% +$418K 0.11% 145
2018
Q3
$7.22M Buy
42,433
+1,018
+2% +$171K 0.08% 177
2018
Q2
$6.79M Buy
41,415
+3,200
+8% +$523K 0.08% 170
2018
Q1
$6.18M Buy
38,215
+2,900
+8% +$462K 0.07% 189
2017
Q4
$5.16M Sell
35,315
-1,700
-5% -$242K 0.06% 209
2017
Q3
$5.02M Sell
37,015
-1,400
-4% -$177K 0.07% 196
2017
Q2
$4.81M Buy
38,415
+1,700
+5% +$203K 0.07% 197
2017
Q1
$4.36M Buy
36,715
+7,000
+24% +$842K 0.07% 202
2016
Q4
$3.43M Sell
29,715
-2,100
-7% -$234K 0.06% 209
2016
Q3
$3.33M Buy
31,815
+2,300
+8% +$240K 0.07% 207
2016
Q2
$2.87M Buy
29,515
+5,000
+20% +$473K 0.06% 218
2016
Q1
$2.35M Buy
24,515
+6,600
+37% +$600K 0.05% 239
2015
Q4
$1.62M Hold
17,915
0.03% 258
2015
Q3
$1.66M Hold
17,915
0.04% 239
2015
Q2
$1.67M Sell
17,915
-300
-2% -$28K 0.04% 247
2015
Q1
$1.73M Hold
18,215
0.04% 255
2014
Q4
$1.61M Buy
18,215
+3,000
+20% +$254K 0.04% 264
2014
Q3
$1.22M Buy
15,215
+1,100
+8% +$82.9K 0.03% 292
2014
Q2
$1M Buy
+14,115
New +$993K 0.02% 324
2013
Q3
Sell
-10,615
Closed -$807K 398
2013
Q2
$807K Buy
+10,615
New +$696K 0.02% 283

Other funds holding CME

DnB Asset Management's CME Position: Q2 2026 in Review

DnB Asset Management increased its CME Group (CME) stake by 3.7% in Q2 2026, buying an estimated $1.16M and bringing the position to 116,514 shares worth $25.7M. The position accounts for 0.07% of the portfolio, ranked #181.

DnB Asset Management first reported a position in CME in Q2 2013 and has held it in 50 quarters since. The position peaked at $33.9M in Q1 2025. 1,124 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • DnB Asset Management held 116,514 shares of CME Group worth $25.7M as of Q2 2026.
  • DnB Asset Management bought 4,207 CME Group shares in Q2 2026, an estimated $1.16M.
  • CME Group made up 0.07% of DnB Asset Management's portfolio in Q2 2026, its #181 holding.
  • DnB Asset Management first reported a position in CME Group in Q2 2013 and has held it in 50 quarters since.
  • DnB Asset Management's CME Group position peaked at $33.9M in Q1 2025.
  • 1,124 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.